US Stock MarketDetailed Quotes

BLUE bluebird bio

Watchlist
  • 1.030
  • -0.020-1.90%
Close May 17 16:00 ET
  • 1.040
  • +0.010+0.97%
Pre 04:06 ET
198.52MMarket Cap-1634P/E (TTM)

About bluebird bio Company

bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.

Company Profile

SymbolBLUE
Company Namebluebird bio
Listing DateJun 19, 2013
Issue Price17.00
Founded1992
CEOMr. Andrew Obenshain
MarketNASDAQ
Employees323
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address455 Grand Union Boulevard
CitySomerville
ProvinceMassachusetts
CountryUnited States of America
Zip Code02145
Phone1-339-499-9300

Company Executives

  • Name
  • Position
  • Salary
  • Andrew Obenshain
  • Director, President and Chief Executive Officer
  • 1.81M
  • Joseph Vittiglio
  • Chief Legal and Business Officer
  • --
  • Christopher Krawtschuk
  • Chief Financial Officer, Principal Accounting Officer and Treasurer
  • --
  • Thomas J. Klima
  • Chief Commercial and Operating Officer
  • 1.25M
  • Richard A. Colvin
  • Chief Medical Officer
  • 1.36M
  • Nick Leschly
  • Director
  • 27.31K
  • Richard Paulson
  • Director
  • --
  • Mark Vachon
  • Independent Director
  • 142.23K
  • Najoh Tita-Reid
  • Independent Director
  • 84.81K
  • Dr. Elisabeth Leiderman, M.D.
  • Independent Director
  • 97.81K
  • Dr. Charlotte Jones-Burton
  • Independent Director
  • 108.87K
  • Dr. John O. Agwunobi
  • Independent Director
  • 91.31K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg